Type 2 Diabetes clinical trials
Showing 151–200 of 391 active trials. Describe your situation to see which ones you may be eligible for.
- Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure
- Human Immunodeficiency Virus (HIV) Food Insecurities
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
- Healthy Living Anson Study
- Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
- Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- Mechanism of SGLT2 Inhibition in the Kidney
- iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
- ROME GS System Study
- ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
- Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
- Preventing Type 2 Diabetes in Black Emergent Adult
- Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls
- SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
- Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia
- Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
- Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
- Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
- Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes
- Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D
- Enhancing Diabetes Care: Exposome &Amp; Sensors
- Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
- Pharmacist-led Continuous Glucose Monitoring
- DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
- A Study of Glycemic Control in Left Ventricular Assist
- A Causative Role for Amylin in Diabetic Peripheral Neuropathy
- A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- Transformative Research in Diabetic Nephropathy 2.0
- Drug Interaction Potential of Pro-Inflammatory Conditions
- Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
- EVOC - EVs in Obesity and Cardiometabolic Disease
- Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population
- Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus
- Circulating Biomarkers in the Development of Type 1 Diabetes
- Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
- Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Gut Microbiota in Metabolic Surgery
- Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.